Plasmacytoma - 153 Studies Found

Recruiting : Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting
: Multiple Myeloma
: 2013-09-17
:
  • Drug: Pomalidomide Other Name:
Recruiting : Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma
: Multiple Myeloma
: 2010-09-09
: Drug: CX-4945 CX-4945 capsules, administered orally,as escalating doses. Dose schedule: four times daily
Active, not recruiting : Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
:
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Neurotoxicity

: 2008-11-14
:
  • Drug: bortezomib Given IV
Terminated : Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan
:
  • Mucositis
  • Multiple Myeloma and Plasma Cell Neoplasm

: 2008-01-22
: Other: laboratory biomarker analysis Blood or cheek cells wil be collected.
Completed : Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma
:
  • Anemia
  • Multiple Myeloma
  • Plasma Cell Neoplasm

: 2006-11-16
: Biological: epoetin alfa Epoetin alfa will be administered 80,000 u sc every week commencing on study da
Terminated : CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant
:
  • Germ Cell Tumor
  • Leukemia
  • Lymphoma
  • Biological: keyhole limpet hemocyanin

Completed : Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma
:
  • Multiple Myeloma
  • Plasma Cell Neoplasm

: 2005-07-08
:
  • Drug: chemoprotection
  • Procedure: complemen
Completed : Vaccine Therapy in Treating Patients With Multiple Myeloma
:
  • Stage II Multiple Myeloma
  • Stage III Multiple Myeloma
  • Refra
    : 2007-03-01
    :
    • Drug: autologous tumor cell vaccine
    • Drug:

Completed : Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia
:
  • Lymphoma
  • Multiple Myeloma and Plasma Cell Neoplasm

: 1999-11-01
:
  • Drug: antineoplaston A10
  • Drug: antineoplas
Completed : Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma
:
  • Multiple Myeloma
  • Stem Cell Transplantation

: 2008-10-22
: Procedure: allogeneic hematopoietic SCT
<<< Previous | Next >>>